T cell profiling reveals high CD4(+)CTLA-4(+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

S.J.A.M. Santegoets, A.G.M. Stam, S.M. Lougheed, H. Gall, P.E.T. Scholten, M. Reijm, K. Jooss, N. Sacks, K. Hege, I. Lowy, J.M. Cuillerot, B.M.E. von Blomberg, R.J. Scheper, A.J.M. van den Eertwegh, W.R. Gerritsen, T.D. de Gruijl

Research output: Contribution to journalArticleAcademicpeer-review

76 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)245-256
JournalCancer immunology and immunotherapy
Issue number2
Publication statusPublished - 2013

Cite this